Anti-HER2 Monoclonal Antibody MGAH22

A Fc-domain optimized IgG monoclonal antibody directed against the human epidermal growth factor receptor 2 (HER2) with potential immunomodulating and antineoplastic activities. After binding to HER2 on the tumor cell surface, anti-HER2 monoclonal antibody MGAH22 may induce an antibody-dependent cell-mediated cytotoxicity (ADCC) against tumor cells overexpressing HER2. HER2, a tyrosine kinase receptor, is overexpressed by many cancer cell types. Compared to other anti-HER2 monoclonal antibodies, the Fc domain of MGAH22 is optimized with increased binding to the activating Fcgamma receptor IIIA (CD16A), expressed on cells such as natural killer (NK) cells and macrophages, thereby mediating an enhanced ADCC; the Fc domain also shows decreased binding to the inhibitory Fcgamma receptor IIB (CD32B). (NCI Thesaurus)

YOU MAY ALSO LIKE

Anti-HER2 Monoclonal Antibody CT-P6

A monoclonal antibody directed against the human epidermal growth factor receptor 2 (HER2) with potential immunomodulating and antineoplastic activity. After binding to…

Anti-Her-2-CAR Retroviral Vector-Transduced Autologous Peripheral Blood Lymphocytes

Autologous human peripheral blood lymphocytes (PBLs) transduced with a retroviral vector encoding an anti-Her-2 (epidermal growth factor receptor 2) chimeric T cell…

Anti-Hemophilia Factor Unit

One international unit of antihemophilic activity is equivalent to the quantity of antihemophilic factor (Factor VIII) present in 1 mL of normal…

Anti-HBEGF Monoclonal Antibody U3-1565

A humanized monoclonal antibody directed against human heparin-binding EGF-like growth factor (HBEGF) with potential antineoplastic activity. Anti-HBEGF monoclonal antibody U3-1565 binds to…

Anti-HB-EGF Monoclonal Antibody KHK2866

A proprietary fucose-free monoclonal antibody directed against human heparin-binding EGF-like growth factor (HBEGF) with potential antineoplastic activity. Anti-HB-EGF Monoclonal Antibody KHK2866 binds…

Anti-GRP78 Monoclonal Antibody PAT-SM6

A IgM monoclonal antibody (MoAb) against 78-kDa glucose-regulated protein (GRP78; also called BiP or HSPA5), with potential proapoptotic and antineoplastic activities. Upon…